HHS Appeals Court Ruling That Blocked DSH Calculation Changes That Impact 340B Eligibility

The 5th Circuit Court of Appeals will take up a case that Texas hospitals filed against HHS to block changes to how the Medicare DSH payment calculation is determined.
The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pfizer CEO Calls 340B ‘One of the Biggest Issues’ During Earnings Call Touting $17.1B in Quarterly Revenue

Pfizer CEO Albert Bourla told investors that "340B reform is something that myself and the entire pharma [industry] is setting as a priority."
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri

Key briefs were filed this week in state contract pharmacy litigation in Arkansas and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ascend, Xellia Announce Refunds for 340B Overcharges

Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations.
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Much-Needed Wins for 340B Providers but Challenges Could Be Lurking

Ted Slafsky, publisher and CEO of 340B Report, writes about litigation over state 340B contract pharmacy laws.
After a long period in which many 340B providers felt helpless, the last month has brought two major wins. First, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Julie Badger, Technical Training Advisor, Verity Solutions

Julie Badger

Q: Where did you grow up?

Pleasanton, CA

Q: Where did you go to college/graduate school?

University of California Davis

Q: What are your favorites?

Food: I love to cook so it’s hard to pick one thing. My kids’ favorite home cooked meal is my Italian risotto recipe.

Movie:

Read More »

Kalderos to Resume Legal Battle Over HRSA’s Opposition to Drugmaker 340B Restrictions, Including Rebates

Kalderos will soon file an amended complaint in its case against HRSA before the U.S. District Court for the District of Columbia.
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former Presidential Candidate Howard Dean Calls for More 340B Transparency, Declines to Discuss Op-ed, Alleged Drug Industry Ties

Howard Dean urged federal lawmakers in an Oct. 25 RealClearHealth op-ed to pay attention to the 340B program.
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca Announces Change to Cancer Drug Replenishment After Discontinuing Certain Dosage

AstraZeneca recently posted an NDC notice to 340B covered entities regarding replenishment of a cancer medication.
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

UCB Extends Contract Pharmacy Restrictions to All Federal Grantees

UCB announced extended 340B contract pharmacy restrictions that will take effect Nov. 25.
Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live